G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/74 (2006.01)
Patent
CA 2527200
Disclosed are methods of characterising life expectancy of human individuals on the basis of measured relaxin levels. In one aspect of the invention the human individuals are end-stage-kidney-disease patients.
L'invention concerne des méthodes permettant de caractériser l'évaluation de durée de vie d'individus humains sur la base des mesures des niveaux de relaxine. Dans un aspect de l'invention, ces individus humains sont des patients atteints de maladie rénale au stade terminal.
Gehrmann Mathias
Hocher Berthold
Stasch Johannes-Peter
Bayer Healthcare Ag
Smart & Biggar
LandOfFree
Relaxin as an independent risk factor predicting mortality does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Relaxin as an independent risk factor predicting mortality, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relaxin as an independent risk factor predicting mortality will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1700914